8-K//Current report
POINT Biopharma Global Inc. 8-K
Accession 0001193125-23-303512
CIK 0001811764operating
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 8:54 AM ET
Size
277.9 KB
Accession
0001193125-23-303512
Documents
- 8-Kd594310d8k.htmPrimary
FORM 8-K
- EX-3.1d594310dex31.htm
EX-3.1
- EX-3.2d594310dex32.htm
EX-3.2
- EX-101.SCHpnt-20231222.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABpnt-20231222_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREpnt-20231222_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd594310d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-303512-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeoperating
Related Parties
1- filerCIK 0001811764
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 8:54 AM ET
- Size
- 277.9 KB